37
Participants
Start Date
July 7, 2016
Primary Completion Date
January 3, 2022
Study Completion Date
January 3, 2022
Daratumumab
Durvalumab
Pomalidomide
Dexamethasone
Local Institution - 552, Copenhagen
Rigshospitalet University Hospital, Copenhagen
Cliniques Universitaires UCL de Mont-Godine, Yvoir
Local Institution - 551, Vejle
Vejle Hospital, Vejle
AZ St-Jan Brugge Oostende AV, Bruges
Perelman Center for Advanced Medicine, Philadelphia
University of Pennsylvania - Perelman Center for Advanced Medicine, Philadelphia
Center For Cancer and Blood Disorders, Bethesda
Hospital Universitario Fundacion Jimenez Diaz, Madrid
Local Institution - 452, Madrid
Hospital 12 de Octubre, Madrid
A.O.U. Maggiore della Carità, Novara
Local Institution - 353, Novara
Emory University Hospital, Atlanta
Hospital de Cabuenes, Gijón
Local Institution - 451, Gijón
Azienda Ospedaliera di Padova, Padua
Local Institution - 355, Padua
Sarah Cannon Research Institute, Nashville
Tennessee Oncology Nashville Drug Development Unit, Nashville
Local Institution - 354, Bologna
Policlinico S. Orsola - Malpighi, Bologna
A.O. Universitaria Ospedale S.Chiara Dip.Oncologia, Div. Ematologia, Pisa
University of Chicago Medical Center, Chicago
Washington University, St Louis
Local Institution - 203, Heidelberg
Universitatsklinikum Heidelberg, Heidelberg
University Hospital Tubingen, Tübingen
Colorado Blood Cancer Institute, Denver
Local Institution - 007, Denver
Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo
City of Hope National Medical Center, Duarte
Local Institution - 201, Würzburg
Universitatsklinikum Wuerzburg, Würzburg
Swedish Medical Center, Seattle
UCLA Division of Hematology Oncology, Los Angeles
Dana-Farber Partners Cancer Care, Inc., Boston
Hackensack University Medical Center, Hackensack
Universitaire Ziekenhuizen Leuven Univeristy Hospitals Leuven, Leuven
Local Institution - 103, Saint John
Saint John Regional Hospital, Saint John
Local Institution - 104, Toronto
Princess Margaret Cancer Centre, Toronto
Hopital Maisonneuve-Rosemont, Montreal
Local Institution - 101, Montreal
MUHC Glen Site, Montreal
Local Institution - 553, Odense
Odense University Hospital, Odense
Universitatsklinikum Carl Gustav Carus an der TU Dresden, Dresden
Hospital Durán i Reynals - Instituto Catalàn de Oncologìa ICO, Barcelona
Local Institution - 453, Barcelona
Sahlgrenska University Hospital, Gothenburg
Local Institution - 501, Lund
Skanes Universitetssjukhus Malmo, Lund
Local Institution - 502, Stockholm
Karolinska Universitetssjukhuset - Huddinge, Stockholm
St. Bartholomew's and The Royal London Hospital, London
Christie Hospital, Manchester
Local Institution - 252, Oxford
Oxford University Hospitals NHS Trust- Churchill Hospital-Oxford Centre for Respiratory Medicine, Oxford
Local Institution - 253, Sutton (Surrey)
Royal Marsden Hospital, Sutton (Surrey)
The Royal Wolverhampton Hospital NHS Trust, Wolverhampton
Lead Sponsor
Celgene
INDUSTRY